Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1992 2
1995 1
1996 3
1997 1
1998 5
1999 2
2000 6
2001 3
2002 2
2003 5
2004 3
2005 3
2006 4
2007 8
2008 7
2009 6
2010 13
2011 18
2012 7
2013 16
2014 20
2015 23
2016 14
2017 15
2018 25
2019 29
2020 26
2021 22
2022 26
2023 30
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
Chihara D, Arons E, Stetler-Stevenson M, Yuan CM, Wang HW, Zhou H, Raffeld M, Xi L, Steinberg SM, Feurtado J, James L, Wilson W, Braylan RC, Calvo KR, Maric I, Dulau-Florea A, Kreitman RJ. Chihara D, et al. Among authors: maric i. J Clin Oncol. 2020 May 10;38(14):1527-1538. doi: 10.1200/JCO.19.02250. Epub 2020 Feb 28. J Clin Oncol. 2020. PMID: 32109194 Free PMC article. Clinical Trial.
Breath: The Exhaust of Metabolism.
Stevenson DK, Marić I, Wong RJ. Stevenson DK, et al. Among authors: maric i. J Pediatr. 2023 Jun;257:113386. doi: 10.1016/j.jpeds.2023.03.002. Epub 2023 Mar 15. J Pediatr. 2023. PMID: 36925060 No abstract available.
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I, Stetler-Stevenson M, Phan GQ, Hughes MS, Sherry RM, Yang JC, Kammula US, Devillier L, Carpenter R, Nathan DA, Morgan RA, Laurencot C, Rosenberg SA. Kochenderfer JN, et al. Among authors: maric i. Blood. 2012 Mar 22;119(12):2709-20. doi: 10.1182/blood-2011-10-384388. Epub 2011 Dec 8. Blood. 2012. PMID: 22160384 Free PMC article. Clinical Trial.
Data-Driven Modeling of Pregnancy-Related Complications.
Espinosa C, Becker M, Marić I, Wong RJ, Shaw GM, Gaudilliere B, Aghaeepour N, Stevenson DK; Prematurity Research Center at Stanford. Espinosa C, et al. Among authors: maric i. Trends Mol Med. 2021 Aug;27(8):762-776. doi: 10.1016/j.molmed.2021.01.007. Epub 2021 Feb 8. Trends Mol Med. 2021. PMID: 33573911 Free PMC article. Review.
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
Kochenderfer JN, Wilson WH, Janik JE, Dudley ME, Stetler-Stevenson M, Feldman SA, Maric I, Raffeld M, Nathan DA, Lanier BJ, Morgan RA, Rosenberg SA. Kochenderfer JN, et al. Among authors: maric i. Blood. 2010 Nov 18;116(20):4099-102. doi: 10.1182/blood-2010-04-281931. Epub 2010 Jul 28. Blood. 2010. PMID: 20668228 Free PMC article. Clinical Trial.
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Ali SA, Shi V, Maric I, Wang M, Stroncek DF, Rose JJ, Brudno JN, Stetler-Stevenson M, Feldman SA, Hansen BG, Fellowes VS, Hakim FT, Gress RE, Kochenderfer JN. Ali SA, et al. Among authors: maric i. Blood. 2016 Sep 29;128(13):1688-700. doi: 10.1182/blood-2016-04-711903. Epub 2016 Jul 13. Blood. 2016. PMID: 27412889 Free PMC article. Clinical Trial.
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN. Brudno JN, et al. Among authors: maric i. J Clin Oncol. 2018 Aug 1;36(22):2267-2280. doi: 10.1200/JCO.2018.77.8084. Epub 2018 May 29. J Clin Oncol. 2018. PMID: 29812997 Free PMC article.
Predicting Preterm Birth Using Proteomics.
Marić I, Stevenson DK, Aghaeepour N, Gaudillière B, Wong RJ, Angst MS. Marić I, et al. Clin Perinatol. 2024 Jun;51(2):391-409. doi: 10.1016/j.clp.2024.02.011. Epub 2024 Mar 23. Clin Perinatol. 2024. PMID: 38705648 Free PMC article. Review.
Genomics of PDGFR-rearranged hypereosinophilic syndrome.
Rheinbay E, Qi M, Bouyssou JM, Oler AJ, Thumm L, Makiya M, Maric I, Klion AD, Lane AA. Rheinbay E, et al. Among authors: maric i. Blood Adv. 2023 Jun 13;7(11):2558-2563. doi: 10.1182/bloodadvances.2022009061. Blood Adv. 2023. PMID: 36652685 Free PMC article. No abstract available.
Hemodialysis headache.
Milinkovic M, Zidverc-Trajkovic J, Sternic N, Trbojevic-Stankovic J, Maric I, Milic M, Andric B, Nikic P, Jovanovic P, Rosic P, Stojimirovic B. Milinkovic M, et al. Among authors: maric i. Clin Nephrol. 2009 Feb;71(2):158-63. doi: 10.5414/cnp71158. Clin Nephrol. 2009. PMID: 19203508
308 results